113 related articles for article (PubMed ID: 11451930)
21. Gene expression in bronchoalveolar lavage cells from scleroderma patients.
Luzina IG; Atamas SP; Wise R; Wigley FM; Xiao HQ; White B
Am J Respir Cell Mol Biol; 2002 May; 26(5):549-57. PubMed ID: 11970906
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta.
Rihs S; Walker C; Virchow JC; Boer C; Kroegel C; Giri SN; Braun RK
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):600-10. PubMed ID: 8918367
[TBL] [Abstract][Full Text] [Related]
23. Systemic sclerosis, pulmonary fibrosis and anti-MPO antibodies.
Hidalgo-Tenorio C; Càliz R; Gallego M; Jaimez L; Jiménez-Alonso J
Clin Rheumatol; 2005 Nov; 24(6):658-60. PubMed ID: 15719151
[No Abstract] [Full Text] [Related]
24. [Correlation of lymphocytes and PIIINP with the combined pulmonary fibrosis and emphysema].
Wei XH; Wu XY; Wang JH; Thakur A; Ma AQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2010 Jul; 26(7):675-8. PubMed ID: 20619092
[TBL] [Abstract][Full Text] [Related]
25. Circulating T and B lymphocytes in progressive systemic sclerosis.
de Jesus DG; Clancy RL
J Rheumatol; 1975 Sep; 2(3):336-9. PubMed ID: 1081143
[TBL] [Abstract][Full Text] [Related]
26. [Changes in lymphocyte subsets in bronchoalveolar lavage fluid in patients with systemic sclerosis].
Kopiński P; Nalepa P; Wojas-Pelc A; Janowska E; Gil K
Pol Merkur Lekarski; 2000 Jan; 7(43):18-22. PubMed ID: 10765646
[TBL] [Abstract][Full Text] [Related]
27. Activated T cells and cytokines in bronchoalveolar lavages from patients with various lung diseases associated with eosinophilia.
Walker C; Bauer W; Braun RK; Menz G; Braun P; Schwarz F; Hansel TT; Villiger B
Am J Respir Crit Care Med; 1994 Oct; 150(4):1038-48. PubMed ID: 7921434
[TBL] [Abstract][Full Text] [Related]
28. Breg Cells Are Numerically Decreased and Functionally Impaired in Patients With Systemic Sclerosis.
Mavropoulos A; Simopoulou T; Varna A; Liaskos C; Katsiari CG; Bogdanos DP; Sakkas LI
Arthritis Rheumatol; 2016 Feb; 68(2):494-504. PubMed ID: 26414243
[TBL] [Abstract][Full Text] [Related]
29. Subclinical alveolitis in immunologic systemic disorders.
Wallaert B
Lung; 1990; 168 Suppl():974-83. PubMed ID: 2117218
[TBL] [Abstract][Full Text] [Related]
30. Pulmonary cell populations in recipients of bone marrow transplants with interstitial pneumonitis.
Milburn HJ; Poulter LW; Prentice HG; du Bois RM
Thorax; 1989 Jul; 44(7):570-5. PubMed ID: 2672406
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin in the development of systemic sclerosis--relation to disease activity and organ manifestation.
Lorenzen JM; Krämer R; Meier M; Werfel T; Wichmann K; Hoeper MM; Riemekasten G; Becker MO; Haller H; Witte T
Rheumatology (Oxford); 2010 Oct; 49(10):1989-91. PubMed ID: 20647294
[No Abstract] [Full Text] [Related]
32. Pneumonitis in bone marrow transplant recipients results from a local immune response.
Milburn HJ; Du Bois RM; Prentice HG; Poulter LW
Clin Exp Immunol; 1990 Aug; 81(2):232-7. PubMed ID: 2201468
[TBL] [Abstract][Full Text] [Related]
33. The relationship of defective cell-mediated immunity to visceral disease in systemic sclerosis.
Hughes P; Holt S; Rowell NR; Allonby ID; Janis K; Dodd JK
Clin Exp Immunol; 1977 May; 28(2):233-40. PubMed ID: 301448
[TBL] [Abstract][Full Text] [Related]
34. Lymphoid interstitial pneumonia: findings at bronchoalveolar lavage.
Ishizaki T; Miyabo S; Koshino T; Fujimura M; Ueda M; Sato H; Kitagawa M
Eur J Respir Dis; 1985 Aug; 67(2):128-32. PubMed ID: 3876947
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte phenotyping in systemic sclerosis: a flow cytometry analysis of lymphocytes in bronchoalveolar lavage fluid.
Domagała-Kulawik J; Hoser G; Kawalec M; Doboszyńska A; Kawiak J; Droszcz W
Anal Quant Cytol Histol; 1997 Jun; 19(3):264-70. PubMed ID: 9196810
[TBL] [Abstract][Full Text] [Related]
36. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
Witt C; Apostoloff E; Müller GM; Buchali K; Hiepe F; Brenke A; Romberg B; Winsel K
Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
[TBL] [Abstract][Full Text] [Related]
37. Bronchoalveolar lavage fluid findings in patients with chronic hepatitis C virus infection.
Kubo K; Yamaguchi S; Fujimoto K; Hanaoka M; Hayasaka M; Honda T; Sodeyama T; Kiyosawa K
Thorax; 1996 Mar; 51(3):312-4. PubMed ID: 8779138
[TBL] [Abstract][Full Text] [Related]
38. [In vitro reactivity of lymphocytes obtained from patients with diffuse scleroderma].
Onisk Z; Tchórzewski H
Przegl Dermatol; 1975; 62(2):183-6. PubMed ID: 1079955
[No Abstract] [Full Text] [Related]
39. Increased spontaneous production of interleukin-1 together with inhibitory activity in systemic sclerosis.
Westacott CI; Whicher JT; Hutton CW; Dieppe PA
Clin Sci (Lond); 1988 Dec; 75(6):561-7. PubMed ID: 3264777
[TBL] [Abstract][Full Text] [Related]
40. The lung megakaryocytes and pulmonary fibrosis in systemic sclerosis.
Thachil J
Med Hypotheses; 2009 Mar; 72(3):291-3. PubMed ID: 19036527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
